Union Drug Co Ltd - Due diligence report

A 360° intelligence report on Union Drug Co Ltd: trust score, financial health, credit view, compliance, directors, growth and distress sign…

1925-03-26 Kolkata, West Bengal Active Unlisted Active Compliant
Share
Connect MCP
UD Union Drug Co Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Union Drug Co Ltd — 360° Intelligence Report

Generated from MCA filings & public records
95/100
Trust Score
Low Risk

Union Drug Co Ltd is assessed as Low Risk with a Trust Score of 95/100. Union Drug Co Ltd is an active public limited indian non-government company incorporated in 1925, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 11 Aug 2026 from the latest processed filings. Union Drug Co Ltd snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
95/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (3.43 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
BIJNAN BHATTACHARJEE 01234567 Director 01/04/2018 6 yrs Approved
ALOKE NATH BANERJEE 01234567 Director 01/04/2018 6 yrs Approved
PRATIMA BHATTACHARYA 01234567 Director 01/04/2018 6 yrs Approved
SREEPARNA BHATTACHARYA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Operating for 101+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 3.43 cr already registered.
  • Compliance record supports lending.
Investor view85/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
07 Nov 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
19 Feb 2025
Charge created
Others - 75.00 Lakh
Charge created
Others - 1.50 cr
04 Dec 2020
Director ceased
PRATIMA BHATTACHARYA
07 Sep 2020
Director appointed
ALOKE NATH BANERJEE (Director)
02 Jan 2020
Director appointed
SREEPARNA BHATTACHARYA (Nodal Officer)
27 Nov 2019
Director ceased
SREEPARNA BHATTACHARYA
01 Nov 2019
Director ceased
RANENDRA KUMAR BHATTACHARYA
29 Oct 2019
Director appointed
PRATIMA BHATTACHARYA (Director)
29 Mar 2018
Director ceased
ANINDITA BOSE
26 Dec 2016
Director ceased
CHITRALEKHA BHATTACHARYA
28 Mar 2014
Charge created
Others - 1.18 cr
31 Jan 2012
Director ceased
BIRENDRA KUMAR BHATTACHARYA
01 Nov 2011
Director ceased
AMAL KUMAR ROY
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Roma Pharma Private Limited U24231HP1984PTC005933 Himachal Pradesh, Himachal Pradesh, India
J.Y. Block Bearing Company (P) Ltd U29130DL1998PTC096276 New Delhi, Delhi, India
Ruby Organics Private Limited U24112MH2003PTC054674 Mumbai, Maharashtra, India
Resinous Chemicals (India) Private Limited U24100WB2013PTC190170 Kolkata, West Bengal, India
Madan Medicals Private Limited U24231PB1998PTC021854 Punjab, Punjab, India
Pellucid Lifesciences Private Limited U24230GJ2013PTC076652 City Ahmedabad, Gujarat, India
Nuvista Pharmaceuticals Private Limited U24304TG2017PTC115996 Hyderabad, Telangana, India
Chorus Pharmachem Private Limited U24234GJ2008PTC053845 Nandesari, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Union Drug Co Ltd before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Union Drug Co Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Union Drug Co Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 95/100, distress signals and MSME payment-delay disclosures - know whether Union Drug Co Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Union Drug Co Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Union Drug Co Ltd an active company?

Union Drug Co Ltd has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Union Drug Co Ltd financially healthy?

Union Drug Co Ltd has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Union Drug Co Ltd?

Its overall Trust Score is 95/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Union Drug Co Ltd?

Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Union Drug Co Ltd have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Union Drug Co Ltd up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Union Drug Co Ltd?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.